 Intellia Therapeutics, Inc. NASDAQ:NTLA Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Ian Karp - SVP, IR Corporate Communications John Leonard - President, CEO Director David Lebwohl - EVP Chief Medical Officer Laura Sepp-Lorenzino - EVP Chief Scientific Officer John Hayes - Senior Director, Finance Controller Glenn Goddard - EVP, CFO Treasurer Conference Call Participants Swapnil Malekar - Piper Sandler Co. Maurice Raycroft - Jefferies Dae Gon Ha - Stifel, Nicolaus Company Salveen Richter - Goldman Sachs Group Joseph Thome - Cowen and Company Gena Wang - Barclays Bank Luca Issi - RBC Capital Markets Mani Foroohar - SVB Leerink Yanan Zhu - Wells Fargo Securities Jay Olson - Oppenheimer Operator Good morning. My name is Drew, and I will be your conference operator today, and welcome to the Intellia Therapeutics First Quarter 2022 earnings conference call. 